These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 970488)

  • 21. [Chronic facio-lingual dyskinesia in patients treated with neuroleptics].
    Gralewski Z
    Neurol Neurochir Pol; 1973; 7(3):393-8. PubMed ID: 4714195
    [No Abstract]   [Full Text] [Related]  

  • 22. Prolactin responses to neuroleptics in normal and schizophrenic subjects.
    Gruen PH; Sachar EJ; Langer G; Altman N; Leifer M; Frantz A; Halpern FS
    Arch Gen Psychiatry; 1978 Jan; 35(1):108-16. PubMed ID: 23087
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Extrapyramidal motor disorders in neuroleptic therapy (apparent recurring luxation of mandibular joints)].
    von Domarus H
    Dtsch Zahnarztl Z; 1973 Nov; 28(11):1085-8. PubMed ID: 4520088
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical implications of dopaminergic and cholinergic effects of neuroleptic drugs.
    Stimmel GL
    Hosp Pharm; 1976 Feb; 11(2):50-1, 54-6. PubMed ID: 10235740
    [No Abstract]   [Full Text] [Related]  

  • 25. [Use in psychiatry of antiparkinson drugs].
    Bourgeois M; Mazaux JM; Imbert D; Daubech MJ; Daulouède JP; Tignol J
    Ann Med Psychol (Paris); 1976 Oct; 2(3):499-510. PubMed ID: 1020859
    [No Abstract]   [Full Text] [Related]  

  • 26. Cerebrospinal fluid homovanillic acid and hypokinetic side effects of neuroleptics.
    Bowers MB
    Psychopharmacology (Berl); 1985; 85(2):184-6. PubMed ID: 2861619
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The neuroleptic syndrome and central dopamine metabolites.
    Tollefson GD; Garvey MJ
    J Clin Psychopharmacol; 1984 Jun; 4(3):150-3. PubMed ID: 6203936
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug-induced dystonia.
    Swett C
    Am J Psychiatry; 1975 May; 132(5):532-4. PubMed ID: 1119613
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Biochemical mechanisms of extrapyramidal-motoric effect of haloperidol in man].
    Eben E; Ackenheil M; Raese J; Rüther E
    Arzneimittelforschung; 1974 Aug; 24(8):1133-5. PubMed ID: 4479374
    [No Abstract]   [Full Text] [Related]  

  • 30. Clozapine versus perphenazine: the value of the biochemical mode of action of neuroleptics in predicting their therapeutic activity.
    Van Praag HM; Korf J; Dols LC
    Br J Psychiatry; 1976 Dec; 129():547-55. PubMed ID: 1000139
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Extra-pyramidal syndrome caused by neuroleptics].
    Lambert PA
    Encephale; 1973; 62(1):78-105. PubMed ID: 4718697
    [No Abstract]   [Full Text] [Related]  

  • 32. [Clinical trial of tropatepine chlorhydrate as a corrector of syndromes due to neuroleptics].
    Delaunay J; Guibert S
    Ann Med Psychol (Paris); 1976 Jan; 1(1):144-7. PubMed ID: 970819
    [No Abstract]   [Full Text] [Related]  

  • 33. [Tardive Dyskinesia induced by neuroleptics: a survey of 3140 patients in a psychiatric hospital].
    Bourgeois M
    Encephale; 1977; 3(4):299-320. PubMed ID: 611013
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparative study of haloperidol and chlorpromazine in terms of clinical effects and therapeutic reversal with benztropine in schizophrenia. Theoretical implications for potency differences among neuroleptics.
    Singh MM; Kay SR
    Psychopharmacologia; 1975 Aug; 43(2):103-13. PubMed ID: 1103205
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiparkinson medication in the treatment of extrapyramidal side effects: single of multiple daily doses?
    Neu C; Dimascio A; Demirgian E
    Curr Ther Res Clin Exp; 1972 May; 14(5):246-51. PubMed ID: 4623975
    [No Abstract]   [Full Text] [Related]  

  • 36. Recognition and management of acute neuroleptic-induced extrapyramidal motor and mental syndromes.
    Dose M
    Pharmacopsychiatry; 2000 Sep; 33 Suppl 1():3-13. PubMed ID: 11072761
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biochemical research into psychosis.
    van Praag HM; Korf J
    Acta Psychiatr Scand; 1975 May; 51(4):268-84. PubMed ID: 238363
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mass fragmentometric determination of homovanillic acid in lumbar cerebrospinal fluid of schizophrenic patients during treatment with antipsychotic drugs.
    Sedvall G; Fyrö B; Nybäck H; Wiesel FA; Wode-Helgodt B
    J Psychiatr Res; 1974; 11():75-80. PubMed ID: 4461807
    [No Abstract]   [Full Text] [Related]  

  • 39. [Effects of neuroleptic withdrawal on the drug-induced extrapyramidal syndrome of chronic schizophrenia].
    Elie R; Gagnon MA; Gauthier R; Jéquier JC
    Union Med Can; 1975 Jun; 104(6):909-14. PubMed ID: 772906
    [No Abstract]   [Full Text] [Related]  

  • 40. Family history and CSF homovanillic acid pattern during neuroleptic treatment.
    Bowers MB
    Am J Psychiatry; 1984 Feb; 141(2):296-8. PubMed ID: 6140868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.